Cite
Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).
MLA
Mahil, S. K., et al. “Psoriasis Treat to Target: Defining Outcomes in Psoriasis Using Data from a Real-World, Population-Based Cohort Study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).” The British Journal of Dermatology, vol. 182, no. 5, May 2020, pp. 1158–66. EBSCOhost, https://doi.org/10.1111/bjd.18333.
APA
Mahil, S. K., Wilson, N., Dand, N., Reynolds, N. J., Griffiths, C. E. M., Emsley, R., Marsden, A., Evans, I., Warren, R. B., Stocken, D., Barker, J. N., Burden, A. D., & Smith, C. H. (2020). Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR). The British Journal of Dermatology, 182(5), 1158–1166. https://doi.org/10.1111/bjd.18333
Chicago
Mahil, S K, N Wilson, N Dand, N J Reynolds, C E M Griffiths, R Emsley, A Marsden, et al. 2020. “Psoriasis Treat to Target: Defining Outcomes in Psoriasis Using Data from a Real-World, Population-Based Cohort Study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).” The British Journal of Dermatology 182 (5): 1158–66. doi:10.1111/bjd.18333.